NuuVim review

NuuVim for moms: our verdict

The lowest new-patient price on this roster — $79/mo semaglutide, $133/mo tirzepatide — with the genuine rarity of charging the same for an oral tablet as for the injection, though it doesn't publish the refill rate or a verifiable state list. It runs about $79/mo, flat across every dose — toward the affordable end of what we track.

We looked at NuuVim the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What NuuVim actually costs

• Compounded semaglutide — Injection or oral tablet, same price — new GLP-1 patients: $79/mo
• Compounded tirzepatide — Injection or oral tablet, same price — new GLP-1 patients: $133/mo
• Brand-name semaglutide — Brand-name Ozempic: $1498/mo
• Brand-name tirzepatide — Brand-name Zepbound: $1892/mo

That lands below the median ongoing price of about $179 across the providers we track for moms — a real cost advantage.

NuuVim prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.

The medications NuuVim prescribes

NuuVim lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. It can point you toward FDA-approved brand-name medications as well as the compounded versions — approved products carry the manufacturer's own pregnancy and breastfeeding label, which is cleaner to hand to an OB-GYN.

If you prefer an option without needles, check the exact product offered. FDA-approved oral semaglutide tablets have their own clinical trials and prescribing labels. Compounded oral or sublingual products are different: they are not FDA-approved and cannot be assumed equivalent to an approved tablet or injection. Ask the clinician about the formulation, evidence and instructions.

Where it operates. NuuVim lists its coverage as: Not confirmed (see note).

Where NuuVim fits — and where it doesn't — for moms

A good fit if…

• the monthly cost is a real barrier and you want a low, predictable number.
• you want to discuss both semaglutide and tirzepatide with your prescribing clinician.

Look elsewhere if…

• you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.

Trust, safety and oversight

Before choosing NuuVim, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

NuuVim is a genuine bargain for the price — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.